Literature DB >> 17477885

Novel mutations of the extraneuronal monoamine transporter gene in children and adolescents with obsessive-compulsive disorder.

Andreas Lazar1, Susanne Walitza, Alexander Jetter, Manfred Gerlach, Andreas Warnke, Beate Herpertz-Dahlmann, Dirk Gründemann, Gundula Grimberg, Eberhard Schulz, Helmut Remschmidt, Christoph Wewetzer, Edgar Schömig.   

Abstract

Obsessive-compulsive disorder (OCD) is a disease of complex aetiology with a marked genetic component. Impact of the serotonergic system has been reported but the contribution of additional transmitter systems to the pathogenesis seems likely. The extraneuronal monoamine transporter, EMT (SLC22A3), is implicated in non-neuronal termination of noradrenergic signalling in the central nervous system and a candidate gene for a variety of neuropsychiatric disorders. We conducted a case-control study of 84 Caucasian children and adolescents with OCD according to DSM-IV criteria, and healthy adults by comprehensive sequencing of the EMT gene. Additionally, targeted genotype analysis was done with patient-parent trios. Known polymorphisms and frequent haplotypes were not associated with OCD in the present sample. Transmission disequilibrium test was negative for the presumptive cryptic splice site 1233G>A polymorphism. However, we identified two novel independent mutations exclusively in affected patients. A thus far unknown -106/107delAG mutation was detected in three male patients of unaffected parents but was not prevalent in 204 healthy subjects (p=0.024). In a luciferase reporter assay the mutant allele conferred increased promoter activity by 36%. Furthermore, we describe the first non-synonymous substitution in the EMT gene, Met370Ile, in a family of affected female members that co-segregated with the disease. The residue exhibits a high degree of inter-species conservation. Heterologous expression of mutant cDNA revealed a 40% decline of transport capacity for norepinephrine. Rare mutations in the EMT gene suggest a causative or modulating role in genetic subtypes of OCD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17477885     DOI: 10.1017/S1461145707007742

Source DB:  PubMed          Journal:  Int J Neuropsychopharmacol        ISSN: 1461-1457            Impact factor:   5.176


  12 in total

1.  DNA methylation signatures within the human brain.

Authors:  Christine Ladd-Acosta; Jonathan Pevsner; Sarven Sabunciyan; Robert H Yolken; Maree J Webster; Tiffany Dinkins; Pauline A Callinan; Jian-Bing Fan; James B Potash; Andrew P Feinberg
Journal:  Am J Hum Genet       Date:  2007-11-01       Impact factor: 11.025

2.  Cefdinir for recent-onset pediatric neuropsychiatric disorders: a pilot randomized trial.

Authors:  Tanya K Murphy; E Carla Parker-Athill; Adam B Lewin; Eric A Storch; P Jane Mutch
Journal:  J Child Adolesc Psychopharmacol       Date:  2014-10-09       Impact factor: 2.576

3.  Role of organic cation transporter 3 (SLC22A3) and its missense variants in the pharmacologic action of metformin.

Authors:  Ligong Chen; Bradley Pawlikowski; Avner Schlessinger; Swati S More; Doug Stryke; Susan J Johns; Michael A Portman; Eugene Chen; Thomas E Ferrin; Andrej Sali; Kathleen M Giacomini
Journal:  Pharmacogenet Genomics       Date:  2010-11       Impact factor: 2.089

4.  Decreased anxiety in mice lacking the organic cation transporter 3.

Authors:  Thomas Wultsch; Gundula Grimberg; Angelika Schmitt; Evelin Painsipp; Heike Wetzstein; Alexandra Frauke Stephanie Breitenkamp; Dirk Gründemann; Edgar Schömig; Klaus-Peter Lesch; Manfred Gerlach; Andreas Reif
Journal:  J Neural Transm (Vienna)       Date:  2009-03-11       Impact factor: 3.575

Review 5.  Drug transporters in the human blood-placental barrier.

Authors:  Kirsi Vähäkangas; Päivi Myllynen
Journal:  Br J Pharmacol       Date:  2009-09-25       Impact factor: 8.739

Review 6.  Functional and Biochemical Consequences of Disease Variants in Neurotransmitter Transporters: A Special Emphasis on Folding and Trafficking Deficits.

Authors:  Shreyas Bhat; Ali El-Kasaby; Michael Freissmuth; Sonja Sucic
Journal:  Pharmacol Ther       Date:  2020-12-10       Impact factor: 12.310

Review 7.  The genetics of obsessive-compulsive disorder: a review.

Authors:  David L Pauls
Journal:  Dialogues Clin Neurosci       Date:  2010       Impact factor: 5.986

8.  Evaluation of genetic variations in organic cationic transporter 3 in depressed and nondepressed subjects.

Authors:  Nina Hengen; Mitsi H Lizer; Robert S Kidd
Journal:  ISRN Pharmacol       Date:  2011-08-14

9.  Genetic and epigenetic regulation of the organic cation transporter 3, SLC22A3.

Authors:  L Chen; C Hong; E C Chen; S W Yee; L Xu; E U Almof; C Wen; K Fujii; S J Johns; D Stryke; T E Ferrin; J Simko; X Chen; J F Costello; K M Giacomini
Journal:  Pharmacogenomics J       Date:  2012-01-10       Impact factor: 3.550

10.  Organic Cation Transporters in Psychiatric Disorders.

Authors:  Lynette C Daws
Journal:  Handb Exp Pharmacol       Date:  2021
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.